APA (7th ed.) Citation

S, O., E, P., B, P., V, R., R, B., M, M., . . . MR, D. M. (2023). Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype. Scientific reports, 13(1), 12869. https://doi.org/10.1038/s41598-023-40071-2

Chicago Style (17th ed.) Citation

S, Orrù, et al. "Biomarker Dynamics Affecting Neoadjuvant Therapy Response and Outcome of HER2-positive Breast Cancer Subtype." Scientific Reports 13, no. 1 (2023): 12869. https://doi.org/10.1038/s41598-023-40071-2.

MLA (9th ed.) Citation

S, Orrù, et al. "Biomarker Dynamics Affecting Neoadjuvant Therapy Response and Outcome of HER2-positive Breast Cancer Subtype." Scientific Reports, vol. 13, no. 1, 2023, p. 12869, https://doi.org/10.1038/s41598-023-40071-2.